| 2024-03-04 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 2,447 0.0027% | $7.77 | $19,013 | -40.96% | |
| 2024-01-29 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 1,849 0.0017% | $5.00 | $9,245 | -0.22% | |
| 2024-01-09 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 7,028 0.0071% | $4.37 | $30,712 | +8.96% | |
| 2024-01-02 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 5,182 0.0052% | $3.66 | $18,966 | +30.08% | |
| 2023-12-18 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 1,585 0.0018% | $3.50 | $5,548 | +43.76% | |
| 2023-08-18 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 4,718 0.0048% | $2.80 | $13,210 | +33.09% | |
| 2023-07-05 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 5,182 0.0053% | $4.83 | $25,029 | -22.69% | |
| 2023-01-10 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 7,331 0.0071% | $5.24 | $38,414 | -13.57% | |
| 2022-08-18 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 4,703 0.0048% | $29.75 | $139,914 | -80.03% | |
| 2022-01-11 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 1,770 0.0019% | $48.45 | $85,757 | -43.63% | |
| 2021-12-20 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 15,977 0.0168% | $60.00 | $958,620 | -51.66% | |
| 2021-09-28 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 19,460 0.021% | $62.53 | $1.22M | -42.11% | |
| 2021-08-19 | Sale | Fate Therapeutics, Inc. FATE | Chief Financial Officer | 3,474 0.0038% | $88.26 | $306,602 | -55.38% |